Verucerfont

CAS: 885220-61-1

Ref. 3D-KKB22061

Produktinformation

• Name: Verucerfont
• Synonyme: Pyrazolo[1,5-a]pyrimidin-7-amine, 3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]-, NBI 77860, 3-(4-Methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]pyrazolo[1,5-a]pyrimidin-7-amine, GSK 561679A

Beschreibung

Verucerfont is a drug that binds to the glucocorticoid receptor and inhibits transcription. It has been shown to have potent anti-inflammatory effects in mouse models of inflammatory diseases, such as arthritis and colitis, by inhibiting cytokine production. Verucerfont also potently inhibits the synthesis of proinflammatory cytokines in human cells, including IL-1β, IL-6, and TNFα. Verucerfont has not been shown to be effective for treating inflammatory diseases in women.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 406.48 g/mol
• Formel: C₂₂H₂₆N₆O₂
• Reinheit: Min. 95%